Posts by Follicle Thought
Rophe Pharma Announces Eyebrow Growth
Rophe Pharma submitted a press release this week announcing its topical hair growth drug has shown positive results for restoring eyebrows. Rophe’s hair growth candidate RPHE-7193 is a topical form of the FDA approved blood pressure drug hydralazine. The drug apparently has a similar mechanism to minoxidil. Here’s a quote from the press release which…
Read MoreFollicum’s Year End Greetings
Gunnar Gardemyr of Follicum recently reached out to Follicle Thought to share some messages with its readers regarding the progress of Follicum and details on what the company is looking forward to next year. Follicum is casually strolling into a major pivotal position in the hair growth industry and also has in the works some new…
Read MoreStay Updated: South Korea Hair Growth Research & More
I’ve had a few readers asking about updates lately which tells me that not everyone is aware of the new Updates thread. It is a post that acts as a Newsfeed. I use it to add quick news items and links to articles. These are for news items that do not necessitate an entire published…
Read MoreQuark Pharmaceuticals: WCHR2017 Presentation
As I was reading the program of the 10th World Congress for Hair Research, a few of the oral presentations caught my eye. One such presentation was titled “Topical application of siRNA against androgen receptor for treatment of androgenic alopecia and female pattern of hair loss” by Quark Pharmaceuticals. Quark is new to the scene of…
Read MoreNew Company: Brickell Biotech
Brickell Biotech, a dermatology-focused pharmaceutical company, is developing a therapy which should prove to be of interest to the online hair community. The company is based in Boulder, CO and has a variety of clinical programs underway in the area of dermatology. One such program is an oral CRTH2 antagonist for hair loss. A “CRTH2…
Read MoreUpdates – Cures for Hair Loss 2023
This article is a news feed containing brief updates of the most important hair growth treatment and hair loss cure news. It’s updated several times a week.
Read MoreLEO Science & Tech Hub: Alopecia Areata Research
Located within the biotech cluster which is Cambridge, Massachusetts sits a contemporary R&D platform, the LEO Science & Tech Hub. The Science & Tech Hub is an innovation unit of the international dermatology-focused LEO Pharma company. The Tech Hub seeks to engage with and bolster new technology which may offer solutions to dermatological and other…
Read MoreRophe Pharma Announces Hair Growth Candidate
It was recently announced that Rophe Pharma will enter the hair growth market with a repurposed drug candidate. Robert Gadimian, CEO of Rophe Pharma, has put out a press release this month pertaining to the development of his hair growth compound RPHE-7193. See below for text of press release. “Rophe Pharma, announces it has applied…
Read MoreRiverTown Therapeutics Inc. Clinical Update
I’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…
Read MoreAsia: Hair Growth R&D
Just when we thought we knew of every company in the world working on hair growth treatments… With all of the scientific articles on hair biology that continually get published from Asian establishments there was bound to be a few companies springing up at some point. I’m happy to say I’ve got 4 new companies…
Read More